ARCHIVES

Autologous BMT Equivalent To Allogeneic For Myeloma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

More Surgical Patients Die When Nurse Caseloads Rise

November 29, 2002

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010

In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work

June 20, 1986

RFA: Long-Term Cancer Survivors

September 12, 1997

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008